Self-reported glaucoma in Canada: Findings from population-based surveys, 1994-2003

Canadian Journal of Ophthalmology

Volumn 42, Issue 2, 2007, Pages 219-226

  Perruccio, Anthony V ^a   Badley, Elizabeth M ^a   Trope, Graham E ^b,c  

^a UNIVERSITY OF TORONTO   (Canada)

^b TORONTO WESTERN HOSPITAL   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

Author keywords

Canada; Glaucoma; Health survey; Population

Indexed keywords

ARTHRITIS; ARTICLE; CANADA; COST EFFECTIVENESS ANALYSIS; DIABETES MELLITUS; DISEASE ASSOCIATION; EDUCATIONAL STATUS; GLAUCOMA; GROUPS BY AGE; HEALTH SURVEY; HUMAN; HYPERTENSION; INCOME; MEDICAL PROFESSION; MIGRAINE; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; POPULATION RESEARCH; PREVALENCE; SELF REPORT; SEX DIFFERENCE;

EID: 34248176826     PISSN: 00084182     EISSN: 17153360     Source Type: Journal    
DOI: 10.3129/can.j.ophthalmol.i07-001     Document Type: Article

References (83)

1. Quigley HA. Number of people with glaucoma worldwide. Br J Ophthalmol 1996;80:389-93.
2. Goldberg I. Relationship between intraocular pressure and preservation of visual field in glaucoma. Surv Ophthalmol 2003;48(Suppl 1):S3-S7.
3. Kass MA, Heuer DK, Higginbotham, EJ, et al. The Ocular Hypertension Treatment Study: a randomized trial determines that topical ocular hypotensive medication delays or prevents the onset of primary open-angle glaucoma. Arch Ophthalmol 2002;120:701-13.
4. Quigley HA. Open-angle glaucoma. N Engl J Med 1993;328: 1097-106.
5. Schulzer M. Intraocular pressure reduction in normal-tension glaucoma patients. The Normal Tension Glaucoma Study Group. Ophthalmology 1992;99:1468-70.
6. Sommer A. Intraocular pressure and glaucoma. Am J Ophthalmol 1989;107:186-8.
7. Wax MB, Camras CB, Fiscella RG, Girkin C, Singh K, Weinreb RN. Emerging perspectives in glaucoma: optimizing 24-hour control of intraocular pressure. Am J Ophthalmol 2002;133 Suppl:S1-10.
8. Sommer A, Tielsch JM, Katz J, et al. Relationship between intraocular pressure and primary open angle glaucoma among white and black Americans. The Baltimore Eye Survey. Arch Ophthalmol 1991;109:1090-5.
9. Quigley HA, Katz J, Derick RJ, Gilbert D, Sommer A. An evaluation of optic disc and nerve fiber layer examinations in monitoring progression of early glaucoma damage. Ophthalmology 1992;99:19-28.
10. Varma R, Quigley HA, Pease ME. Changes in optic disk characteristics and number of nerve fibers in experimental glaucoma. Am J Ophthalmol 1992;114:554-9.
11. Coleman AL. Glaucoma. Lancet 1999;354:1803-10.
12. The Glaucoma Foundation. About glaucoma: who is at risk? New York, NY: Glaucoma Foundation 2007. Available: http://www.glaucomafoundation.org (accessed 2007 Jan 25).
13. The Glaucoma Research Foundation. About glaucoma: risk factors. San Francisco, Calif: Glaucoma Research Foundation. Available: http://www.glaucoma. org (accessed 2007 Jan 25).
14. Sommer A. Doyne Lecture. Glaucoma: facts and fancies. Eye 1996;10(Pt3):295-301.
15. Tielsch JM, Sommer A, Katz J, Royall RM, Quigley HA, Javitt J. Racial variations in the prevalence of primary open-angle glaucoma. The Baltimore Eye Survey. JAMA 1991;266: 369-74.
16. Leske MC, Connell AM, Schachat AP, Hyman L. The Barbados Eye Study. Prevalence of open angle glaucoma. Arch Ophthalmol 1994;112:821-9.
17. Mason RP, Kosoko O, Wilson MR, et al. National survey of the prevalence and risk factors of glaucoma in St. Lucia, West Indies. Part I. Prevalence findings. Ophthalmology 1989;96: 1363-8.
18. Hu CN. An epidemiologic study of glaucoma in Shunyi County, Beijing [in Chinese]. Zhonghua Yan Ke Za Zhi 1989;25:115-9.
19. Jacob A, Thomas R, Koshi SP, Braganza A, Muliyil J. Prevalence of primary glaucoma in an urban south Indian population. Indian J Ophthalmol 1998;46:81-6.
20. Seah SK, Foster PJ, Chew PT, et al. Incidence of acute primary angle-closure glaucoma in Singapore. An island-wide survey. Arch Ophthalmol 1997;115:1436-40.
21. Booth A, Churchill A, Anwar R, Menage M, Markham A. The genetics of primary open angle glaucoma. Br J Ophthalmol 1997;81:409-14.
22. Tielsch JM, Katz J, Sommer A, Quigley HA, Javitt JC. Family history and risk of primary open angle glaucoma. The Baltimore Eye Survey. Arch Ophthalmol 1994;112:69-73.
23. Wolfs RC, Klaver CC, Ramrattan RS, van Duijn CM, Hofman A, de Jong PT. Genetic risk of primary open-angle glaucoma. Population-based familial aggregation study. Arch Ophthalmol 1998;116:1640-5.
24. Ponte F, Giuffre G, Giammanco R, Dardanoni G. Risk factors of ocular hypertension and glaucoma. The Casteldaccia Eye Study. Doc Ophthalmol 1994;85:203-10.
25. Mastropasqua L, Lobefalo L, Mancini A, Ciancaglini M, Palma S. Prevalence of myopia in open angle glaucoma. Eur J Ophthalmol 1992;2:33-5.
26. Tielsch JM, Katz J, Quigley HA, Javitt JC, Sommer A. Diabetes, intraocular pressure, and primary open-angle glaucoma in the Baltimore Eye Survey. Ophthalmology 1995;102: 48-53.
27. Klein BE, Klein R, Jensen SC. Open-angle glaucoma and older-onset diabetes. The Beaver Dam Eye Study. Ophthalmology 1994;101:1173-7.
28. Mitchell P, Smith W, Chey T, Healey PR. Open-angle glaucoma and diabetes: the Blue Mountains eye study, Australia. Ophthalmology 1997;104:712-8.
29. Tielsch JM, Katz J, Sommer A, Quigley HA, Javitt JC. Hypertension, perfusion pressure, and primary open-angle glaucoma. A population-based assessment. Arch Ophthalmol 1995;113:216-21.
30. Dielemans I, Vingerling JR, Algra D, Hofman A, Grobbee DE, de Jong PT. Primary open-angle glaucoma, intraocular pressure, and systemic blood pressure in the general elderly population. The Rotterdam Study. Ophthalmology 1995;102: 54-60.
31. The International Bank for Reconstruction and Development/ the World Bank. World Development Report 1993. New York, NY: Oxford University Press; 1993.
32. Statistics Canada. National Population Health Survey Cycle 1 (1994-1995); public use microdata files. Ottawa, Ont: Statistics Canada; 1995.
33. Statistics Canada. National Population Health Survey Cycle 2 (1996-1997); public use microdata files. Ottawa, Ont: Statistics Canada; 1997.
34. Statistics Canada. National Population Health Survey Cycle 3 (1998-1999); public use microdata files. Ottawa, Ont: Statistics Canada; 1999.
35. Statistics Canada. Canadian Community Health Survey Cycle 1.1 (2000-2001); public use microdata files. Ottawa, Ont: Statistics Canada; 2001.
36. Statistics Canada. Canadian Community Health Survey Cycle 2.1 (2002-2003); public use microdata files. Ottawa, Ont: Statistics Canada; 2003.
37. Cedrone C, Culasso F, Cesareo M, Zapelloni A, Cedrone P, Cerulli L. Prevalence of glaucoma in Ponza, Italy: a comparison with other studies. Ophthalmic Epidemiol 1997;4:59-72.
38. Coffey M, Reidy A, Wormald R, Xian WX, Wright L, Courtney P. Prevalence of glaucoma in the west of Ireland. Br J Ophthalmol 1993;77:17-21.
39. Giuffre G, Giammanco R, Dardanoni G, Ponte F. Prevalence of glaucoma and distribution of intraocular pressure in a population. The Casteldaccia Eye Study. Acta Ophthalmol Scand 1995;73:222-5.
40. Kahn HA, Milton RC. Alternative definitions of open-angle glaucoma. Effect on prevalence and associations in the Framingham eye study. Arch Ophthalmol 1980;98:2172-7.
41. Klein BE, Klein R, Sponsel WE, et al. Prevalence of glaucoma. The Beaver Dam Eye Study. Ophthalmology 1992;99:1499-504.
42. Mitchell P, Smith W, Attebo K, Healey PR. Prevalence of open-angle glaucoma in Australia. The Blue Mountains Eye Study. Ophthalmology 1996;103:1661-9.
43. Shiose Y, Kitazawa Y, Tsukahara S, et al. Epidemiology of glaucoma in Japan: a nationwide glaucoma survey. Jpn J Ophthalmol 1991;35:133-55.
44. Tielsch JM, Katz J, Singh K, et al. A population-based evaluation of glaucoma screening: the Baltimore Eye Survey. Am J Epidemiol 1991;134:1102-10.
45. Anton A, Andrada MT, Mujica V, Calle MA, Portela J, Mayo A. Prevalence of primary open-angle glaucoma in a Spanish population: the Segovia study. J Glaucoma 2004;13:371-6.
46. Friedman DS, Wolfs RC, O'Colmain BJ, et al. Prevalence of open-angle glaucoma among adults in the United States. Arch Ophthalmol 2004;122:532-8.
47. Tuck MW, Crick RP. The projected increase in glaucoma due to an ageing population. Ophthalmic Physiol Opt 2003;23:175-9.
48. Rochtchina E, Mitchell P. Projected number of Australians with glaucoma in 2000 and 2030. Clin Experiment Ophthalmol 2000;28:146-8.
49. Hylton C, Congdon N, Friedman D, et al. Cataract after glaucoma filtration surgery. Am J Ophthalmol 2003;135:231-2.
50. The Advanced Glaucoma Intervention Study: 8. Risk of cataract formation after trabeculectomy. Arch Ophthalmol 2001;119:1771-9.
51. Chandrasekaran S, Cumming RG, Rochtchina E, Mitchell P. Associations between elevated intraocular pressure and glaucoma, use of glaucoma medications, and 5-year incident cataract: the Blue Mountains Eye Study. Ophthalmology 2006;113:417-24.
52. Allen DB, Bielory L, Derendorf H, Dluhy R, Colice GL, Szefler SJ. Inhaled corticosteroids: past lessons and future issues. J Allergy Clin Immunol 2003;112(3 Suppl):S1-40.
53. Carnahan MC, Goldstein DA. Ocular complications of topical, periocular, and systemic corticosteroids. Curr Opin Ophthalmol 2000;11:478-83.
54. McLean CJ, Lobo RF, Brazier DJ. Cataracts, glaucoma, and femoral avascular necrosis caused by topical corticosteroid ointment. Lancet 1995;345:330.
55. Costagliola C, Cati-Giovannelli B, Piccirillo A, Delfino M. Cataracts associated with long-term topical steroids. Br J Dermatol 1989;120:472-3.
56. Nielsen NV, Sorensen PN. Glaucoma induced by application of corticosteroids to the periorbital region. Arch Dermatol 1978;114:953-4.
57. Aggarwal RK, Potamitis T, Chong NH, Guarro M, Shah P, Kheterpal S. Extensive visual loss with topical facial steroids. Eye 1993;7(Pt 5):664-6.
58. Landers J, Goldberg I, Graham SL. Analysis of risk factors that may be associated with progression from ocular hypertension to primary open angle glaucoma. Clin Experiment Ophthalmol 2002;30:242-7.
59. Bonovas S, Peponis V, Filioussi K. Diabetes mellitus as a risk factor for primary open-angle glaucoma: a meta-analysis. Diabet Med 2004;21:609-14.
60. Leske MC, Wu SY, Nemesure B, Hennis A. Incident open-angle glaucoma and blood pressure. Arch Ophthalmol 2002;120:954-9.
61. Bonomi L, Marchini G, Marraffa M, Bernardi P, Morbio R, Varotto A. Vascular risk factors for primary open angle glaucoma: the Egna-Neumarkt Study. Ophthalmology 2000;107:1287-93.
62. Mitchell P, Lee AJ, Rochtchina E, Wang JJ. Open-angle glaucoma and systemic hypertension: the blue mountains eye study. J Glaucoma 2004;13:319-26.
63. Yamamoto T, Kitazawa Y. Vascular pathogenesis of normal-tension glaucoma: a possible pathogenetic factor, other than intraocular pressure, of glaucomatous optic neuropathy. Prog Retin Eye Res 1998;17:127-43.
64. Klein BE, Klein R, Meuer SM, Goetz LA. Migraine headache and its association with open-angle glaucoma: the Beaver Dam Eye Study. Invest Ophthalmol Vis Sci 1993;34:3024-7.
65. Usui T, Iwata K, Shirakashi M, Abe H. Prevalence of migraine in low-tension glaucoma and primary open-angle glaucoma in Japanese. Br J Ophthalmol 1991;75:224-6.
66. Wang JJ, Mitchell P, Smith W. Is there an association between migraine headache and open-angle glaucoma? Findings from the Blue Mountains Eye Study. Ophthalmology 1997;104: 1714-9.
67. Cursiefen C, Wisse M, Cursiefen S, Junemann A, Martus P, Korth M. Migraine and tension headache in high-pressure and normal-pressure glaucoma. Am J Ophthalmol 2000;129:102-4.
68. Phelps CD, Corbett JJ. Migraine and low-tension glaucoma. A case-control study. Invest Ophthalmol Vis Sci 1985;26: 1105-8.
69. Hamideh F, Prete PE. Ophthalmologic manifestations of rheumatic diseases. Semin Arthritis Rheum 2001;30:217-41.
70. Silman AJ, Hochberg MC, eds. Epidemiology of the rheumatic diseases. 2nd ed. New York, NY: Oxford University Press Inc; 2001.
71. Lawrence RC, Helmick CG, Arnett FC, et al. Estimates of the prevalence of arthritis and selected musculoskeletal disorders in the United States. Arthritis Rheum 1998;41:778-99.
72. Power JD, Perruccio AV, Desmeules M, Lagace C, Badley EM. Ambulatory physician care for musculoskeletal disorders in Canada. J Rheumatol 2006;33:133-9.
73. Abramson SB. Inflammation in osteoarthritis. J Rheumatol Suppl 2004;70:70-6.
74. Pincus T. Clinical evidence for osteoarthriris as an inflammatory disease. Curr Rheumatol Rep 2001;3:524-34.
75. Beckett M, Weinstein M, Goldman N, Yu-Hsuan L. Do health interview surveys yield reliable data on chronic illness among older respondents? Am J Epidemiol 2000;151:315-23.
76. Haapanen N, Miilunpalo S, Pasanen M, Oja P, Vuori I. Agreement between questionnaire data and medical records of chronic diseases in middle-aged and elderly Finnish men and women. Am J Epidemiol 1997;145:762-9.
77. Heliovaara M, Aromaa A, Klaukka T, Knekt P, Joukamaa M, Impivaara O. Reliability and validity of interview data on chronic diseases. The Mini-Finland Health Survey. J Clin Epidemiol 1993;46:181-91.
78. Iskedjian M, Walker J, Vicente C, et al. Cost of glaucoma in Canada: analyses based on visual field and physicians assessment. J Glaucoma 2003;12:456-62.
79. Patterson C. Screening for visual impairment in the elderly. In: Canadian Task Force on the Periodic Health Examination. The Canadian Guide to Clinical Preventive Health Care. Ottawa, Ont: Health Canada. 1994:932-42. Catalogue H21-117/1994E.
80. Elolia R, Stokes J. Monograph series on aging-related diseases: XI. Glaucoma. Chronic Dis Can 1998;19:157-69.
81. Prevent Blindness America. Vision problems action plan: a national public health strategy 2004. Schaumburg, Ill: Prevent Blindness America; 2004.
82. Health Canada. Economic Burden of Illness in Canada, 1998. Catalogue H21-136/1998E ed. Ottawa, Ont: Public Works and Government Services Canada; 2002. Available: http://ebic-femc.hc-sc.gc.ca (accessed 2007 Jan 25).
83. Nguyen RL, Raja SC, Traboulsi EI. Screening relatives of patients with familial chronic open angle glaucoma. Ophthalmology 2000;107:1294-7.